Skip to content

EBIT at other companies

TFX
TeleflexTFX
$20.18M-73.4%
IAR
Integra LifeSciencesIART
$11.47M+174%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$44.16M+7.6%
PDE
Pro-Dex, Inc.PDEX
$3.09M-15.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's EBIT?
Utah Medical Products (UTMD) reported EBIT of $2.57M in Q1 2026.
How has Utah Medical Products's EBIT changed year-over-year?
Utah Medical Products's EBIT decreased by 18.6% year-over-year, from $3.15M to $2.57M.
What is the long-term trend for Utah Medical Products's EBIT?
Over 4 years (2021 to 2025), Utah Medical Products's EBIT has grown at a -11.8% compound annual growth rate (CAGR), from $18.88M to $11.4M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.